The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease

Background and Aims: The synthetic atypical cannabinoid Abn-CBD, a cannabidiol (CBD) derivative, has been recently shown to modulate the immune system in different organs, but its impact in obesity-related meta-inflammation remains unstudied. We investigated the effects of Abn-CBD on metabolic and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Romero-Zerbo, Silvana Y., García-Fernández, María, Espinosa-Jiménez, Vanesa, Pozo-Morales, Macarena, Escamilla-Sánchez, Alejandro, Sánchez-Salido, Lourdes, Lara, Estrella, Cobo-Vuilleumier, Nadia, Rafacho, Alex, Olveira, Gabriel, Rojo-Martínez, Gemma, Gauthier, Benoit R., González-Mariscal, Isabel, Bermúdez-Silva, Francisco J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067697/
https://www.ncbi.nlm.nih.gov/pubmed/32210914
http://dx.doi.org/10.3389/fendo.2020.00103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067697/
https://www.ncbi.nlm.nih.gov/pubmed/32210914
http://dx.doi.org/10.3389/fendo.2020.00103

Ejemplares similares